摘要
目的探讨中药补骨脂、双氢青蒿素二者配伍对小鼠隐孢子虫病的疗效。研究该合剂对MHC-Ⅱ类抗原表达的调节作用。方法将60只昆明小鼠随机分成5组:A:正常组;B:阳性对照组1;C:1w治疗组;D:阳性对照组2;E:2w治疗组。B、C、D、E四组小鼠经腹股沟皮下注射地塞米松磷酸钠注射液,建立隐孢子虫感染模型。经1w和2w药物治疗后,计数各组小鼠粪便卵囊数量并观察回肠组织中MHC-Ⅱ类抗原的表达。结果所有药物治疗组,粪便卵囊量与阳性对照组相比均明显减少(P(0.05)。在经药物治疗1w组,B组MHC-Ⅱ类抗原的表达显著高于A组(P(0.05),C组与B组无显著性差异。治疗2w后,E组MHC-Ⅱ类抗原的表达与正常对照组A组无差别(P>0.05),D组MHC-Ⅱ类抗原的表达显著低于A组(P<0.05)。结论 MHC-Ⅱ类抗原在隐孢子虫感染小鼠中表达升高,随着虫体感染加重,MHC-Ⅱ类抗原表达受抑;补骨脂、双氢青蒿素合剂可通过调节MHC-Ⅱ类抗原的表达,进而调节宿主免疫应答反应的能力,达到抑杀虫体,修复病损的目的。
To observe the treating function of Fructus Psoraleae and dihydroartemisinin on mouse infected with Cryptosporidium parvum and to research the regulating function of major histocompatibility complex-Ⅱ,60 mice were randomly divided into five groups: normal group A;positive control group-Ⅰ B;one-week treatment group C;positive control group-Ⅱ D;two-week treatment group E.Mice in group B,C,D,and E were injected subcutaneously with dexamethasone.When the mice were infected with C.parvum,they were treated with the medicine respectively.The intestine tissue was observed via HE.The expression of MHC-Ⅱ were observed by immunohistochemistry.The damaged intestine got improved and repaired,and a significant decrease of the amount of C.parvum oocysts in feces was shown in the treated groups(C,E) compared with positive control groups(B,D)(P0.05).In 1-week treatment group,the MHC-Ⅱ expression of group B was higher than that of normal group A.There was no difference between the expression of MHC-Ⅱ in group B and that in group C;in 2-week treatment group,there was no difference between the expression of MHC-Ⅱ in group E and that in group A.The MHC-Ⅱ expression of group D was lower than that of group A and B(P0.05).It's suggested that fructus Psoraleae and dihydroartemisinin are effective to treat mouse cryptosporidiosis.The expression of MHC-Ⅱ might be regulated by the mixture.
出处
《中国人兽共患病学报》
CAS
CSCD
北大核心
2011年第3期196-200,共5页
Chinese Journal of Zoonoses
基金
辽宁省教育厅科学研究计划资助项目部分资金(No.2004D103)
关键词
补骨脂
双氢青蒿素
隐孢子虫
抗原提呈细胞
MHC-Ⅱ类抗原
Fructus Psoraleae
dihydroartemisinin
Cryptosporidium parvum
antigen-presenting cell
major histocompatibility complex-Ⅱ